Serum ferritin-a novel risk factor in acute myocardial infarction

M P Holay1, A A Choudhary, S D Suryawanshi

  • 1Department of Medicine, Indira Gandhi Government Medical College, Nagpur, India. mpholay@rediffmail.com

Insights

High serum ferritin levels are strongly linked to acute myocardial infarction (AMI), independent of other risk factors. This finding highlights iron status as a significant predictor for heart attack risk.

Area of Science:

  • Cardiology
  • Biochemistry
  • Internal Medicine

Background:

  • The association between body iron status and coronary heart disease (CHD) risk remains controversial.
  • Existing studies present conflicting data regarding iron levels and heart disease incidence.

Purpose of the Study:

  • To investigate the relationship between serum ferritin levels and acute myocardial infarction (AMI).
  • To analyze this association using univariate and multivariate models.
  • To determine if high serum ferritin correlates with established cardiovascular risk factors.

Main Methods:

  • A hospital-based case-control study was conducted.
  • 75 AMI patients (cases) were compared with 75 age- and gender-matched controls.
  • Participants were aged between 30-70 years.

Main Results:

  • Median serum ferritin was significantly higher in AMI cases (220 μg/L) versus controls (155 μg/L) (P ≤ 0.0001).
  • Univariate analysis identified high ferritin (> 200 μg/L), diabetes, hypertension, low HDL, and smoking as significant AMI predictors.
  • Multivariate analysis confirmed high serum ferritin as an independent predictor of AMI (adjusted OR=5.72, P < 0.001).
  • Serum ferritin levels were also significantly higher in diabetic patients.

Conclusions:

  • Elevated serum ferritin is a strong and independent risk factor for acute myocardial infarction.
  • Iron status, indicated by serum ferritin, plays a crucial role in AMI development.
  • These findings suggest serum ferritin as a potential biomarker for cardiovascular risk assessment.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...